Published in Int J Mol Sci on December 10, 2012
Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal (2014) 1.47
The link between chronic periodontitis and COPD: a common role for the neutrophil? BMC Med (2013) 0.83
P21-PARP-1 pathway is involved in cigarette smoke-induced lung DNA damage and cellular senescence. PLoS One (2013) 0.82
Fucoxanthin Protects Cultured Human Keratinocytes against Oxidative Stress by Blocking Free Radicals and Inhibiting Apoptosis. Biomol Ther (Seoul) (2013) 0.80
Oxidative Stress Markers in Sputum. Oxid Med Cell Longev (2016) 0.79
Carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators. Aging Dis (2013) 0.78
Master autophagy regulator Transcription factor-EB (TFEB) regulates cigarette smoke induced autophagy-impairment and COPD-emphysema pathogenesis. Antioxid Redox Signal (2016) 0.78
DNA damage and repair capacity in lymphocyte of chronic obstructive pulmonary diseases patients during physical exercise with oxygen supplementation. Multidiscip Respir Med (2016) 0.75
The DNA-damage response in human biology and disease. Nature (2009) 17.86
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J (2004) 16.84
The DNA damage response: making it safe to play with knives. Mol Cell (2010) 16.13
Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem (2004) 14.93
The danger model: a renewed sense of self. Science (2002) 13.85
Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med (2005) 8.49
Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med (2005) 6.13
Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol (2006) 6.00
Chronic obstructive pulmonary disease. Lancet (2012) 4.43
Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med (2009) 4.27
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest (2005) 3.99
Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med (2010) 3.79
DNA demethylation by DNA repair. Trends Genet (2009) 3.49
8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev (2009) 3.46
Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J (2006) 3.42
Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat Struct Mol Biol (2010) 3.27
Autoimmune disease: why and where it occurs. Nat Med (2001) 3.04
Deletion of Ku86 causes early onset of senescence in mice. Proc Natl Acad Sci U S A (1999) 2.97
SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 2.49
SIRT1 regulates the function of the Nijmegen breakage syndrome protein. Mol Cell (2007) 2.42
Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst (2000) 2.33
New insights into the immunology of chronic obstructive pulmonary disease. Lancet (2011) 2.23
Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev (2007) 2.22
The DNA-dependent protein kinase: the director at the end. Immunol Rev (2004) 2.20
Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med (2006) 2.20
DNA-PK: the means to justify the ends? Adv Immunol (2008) 2.14
Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med (1997) 2.12
Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta (2008) 1.96
State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc (2006) 1.92
Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol (2008) 1.91
Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene (2010) 1.87
Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 1.87
SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J Clin Invest (2012) 1.82
Toll-like receptors and acquired immunity. Semin Immunol (2004) 1.79
Aging and cigarette smoke: fueling the fire. Am J Respir Crit Care Med (2006) 1.76
Epigenetic regulation of airway inflammation. Curr Opin Immunol (2007) 1.66
Molecular targets of oxidative stress. Biochem J (2011) 1.60
Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.57
A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J (2009) 1.47
Disruption of the klotho gene causes pulmonary emphysema in mice. Defect in maintenance of pulmonary integrity during postnatal life. Am J Respir Cell Mol Biol (2000) 1.43
Smoking molecular damage in bronchial epithelium. Oncogene (2002) 1.38
p300-mediated acetylation of histone H3 lysine 56 functions in DNA damage response in mammals. J Biol Chem (2010) 1.34
Sequence dependent instability of mononucleotide microsatellites in cultured mismatch repair proficient and deficient mammalian cells. Hum Mol Genet (2002) 1.32
The HIRAN domain and recruitment of chromatin remodeling and repair activities to damaged DNA. Cell Cycle (2006) 1.32
The role and therapeutic potential of prohibitin in disease. Biochim Biophys Acta (2011) 1.32
Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol (2007) 1.30
Airway epithelial cells, cytokines, and pollutants. Am J Respir Crit Care Med (1999) 1.25
The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers (2009) 1.24
Epigenetic control of gene expression in the lung. Am J Respir Crit Care Med (2011) 1.24
The role of infection in the pathogenesis of autoimmune disease. Semin Immunol (1998) 1.23
Autoimmune diseases: genes, bugs and failed regulation. Nat Immunol (2001) 1.20
Decreased histone deacetylase 2 impairs Nrf2 activation by oxidative stress. Biochem Biophys Res Commun (2011) 1.18
Acquired somatic mutations in the molecular pathogenesis of COPD. Trends Pharmacol Sci (2003) 1.17
Telomere shortening in chronic obstructive pulmonary disease. Respir Med (2008) 1.16
Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respir Med (2008) 1.14
Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease. Respiration (2009) 1.14
Oxidative DNA damage in lung tissue from patients with COPD is clustered in functionally significant sequences. Int J Chron Obstruct Pulmon Dis (2011) 1.14
Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci (2010) 1.10
Oxidative damage to nucleic acids in severe emphysema. Chest (2008) 1.10
Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1995) 1.10
Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD. Am J Physiol Lung Cell Mol Physiol (2012) 1.04
DNA damage response. Cold Spring Harb Perspect Biol (2011) 1.03
Telomere length is a biomarker of cumulative oxidative stress, biologic age, and an independent predictor of survival and therapeutic treatment requirement associated with smoking behavior. Am J Ther (2011) 1.02
Cigarette smoke induces nucleic-acid oxidation in lung fibroblasts. Am J Respir Cell Mol Biol (2009) 1.01
Immunohistochemical evaluation of oxidative stress in murine lungs after cigarette smoke exposure. Inhal Toxicol (2003) 1.00
Smoking and health: association between telomere length and factors impacting on human disease, quality of life and life span in a large population-based cohort under the effect of smoking duration. Fundam Clin Pharmacol (2010) 0.97
Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer. Thorax (2011) 0.96
Increased DNA damage in patients with chronic obstructive pulmonary disease who had once smoked or been exposed to biomass. Respir Med (2005) 0.95
Inflammation, chronic obstructive pulmonary disease and aging. Curr Opin Pulm Med (2011) 0.94
A hypothesis for the initiation of COPD. Eur Respir J (2009) 0.94
Decreased small airway and alveolar CD83+ dendritic cells in COPD. Chest (2009) 0.93
Microsatellite DNA instability in COPD. Chest (1999) 0.92
DNA damage as a molecular link in the pathogenesis of COPD in smokers. Eur Respir J (2012) 0.92
Comparison of elastin peptide concentrations in body fluids from healthy volunteers, smokers, and patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1992) 0.91
Elevated urinary 8-hydroxydeoxyguanosine, a biomarker of oxidative stress, and lack of association with antioxidant vitamins in chronic obstructive pulmonary disease. Respirology (2003) 0.91
Spirometric abnormalities in young smokers correlate with increased chemiluminescence responses of activated blood phagocytes. Am Rev Respir Dis (1989) 0.91
Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene. Am J Respir Crit Care Med (2010) 0.89
Environmentally induced autoimmune diseases: potential mechanisms. Environ Health Perspect (1999) 0.89
PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity. Biochem Biophys Res Commun (2010) 0.89
State of the art. Four easy pieces: interconnections between tissue injury, intermediary metabolism, autoimmunity, and chronic degeneration. Proc Am Thorac Soc (2006) 0.88
Autoimmunity: busting the atherosclerotic plaque. Nat Med (2003) 0.86
Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases. Chest (2011) 0.86
Downregulation of lung mitochondrial prohibitin in COPD. Respir Med (2012) 0.86
Poly(ADP-ribosyl)ation is a survival mechanism in cigarette smoke-induced and hydrogen peroxide-mediated cell death. Free Radic Biol Med (2012) 0.83
Microsatellite DNA instability and COPD exacerbations. Eur Respir J (2008) 0.82
Epigenetics in asthma and other inflammatory lung diseases. Epigenomics (2010) 0.81
Microsatellite DNA instability and loss of heterozygosity in bronchial asthma. Eur Respir J (2003) 0.80
Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease. Eur Respir J (2006) 0.80
Somatic DNA alterations in lung epithelial barrier cells in COPD patients. Pulm Pharmacol Ther (2009) 0.79
Laboratory markers for COPD in "susceptible" smokers. Clin Chim Acta (2005) 0.79
Microsatellite instability in patients with chronic obstructive pulmonary disease. Oncol Rep (1996) 0.77
Pathogenic link between chronic obstructive pulmonary disease and squamous cell lung cancer. Expert Rev Respir Med (2007) 0.76
Sleep patterns in patients with acute coronary syndromes. Sleep Med (2010) 1.74
Is a miliary chest pattern always indicative of tuberculosis or malignancy? Respiration (2006) 1.67
Induced sputum versus bronchoalveolar lavage fluid in the evaluation of patients with idiopathic pulmonary fibrosis. Respiration (2005) 1.44
Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung. Respirology (2013) 1.43
Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway inflammation in COPD. Respiration (2007) 1.42
Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med (2007) 1.41
Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest (2004) 1.39
Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest (2005) 1.39
Apoptotic mechanisms in the pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis (2006) 1.31
Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. N Engl J Med (2005) 1.26
Dyspnea assessment and adverse events during sputum induction in COPD. BMC Pulm Med (2006) 1.15
Sleep disordered breathing in patients with acute coronary syndromes. J Clin Sleep Med (2012) 1.14
Preventing exacerbations of COPD--advice from Hippocrates. N Engl J Med (2011) 1.11
Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid. Immunol Cell Biol (2006) 1.10
Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 1.06
Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest (2006) 1.02
Clinical presentation and management of empyema, lung abscess and pleural effusion. Curr Opin Pulm Med (2006) 0.98
Prognostic value of serum tumor markers in patients with lung cancer. Respiration (2002) 0.96
Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med (2004) 0.95
Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions? Respir Med (2004) 0.94
The relationships among hydrogen peroxide in expired breath condensate, airway inflammation, and asthma severity. Chest (2002) 0.94
Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD. Chest (2005) 0.93
Decreased small airway and alveolar CD83+ dendritic cells in COPD. Chest (2009) 0.93
Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. Int J Oncol (2012) 0.93
Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res (2006) 0.92
Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther (2006) 0.92
Smoking and pulmonary fibrosis: novel insights. Pulm Med (2011) 0.92
Severe airway stenosis associated with Crohn's disease: case report. BMC Pulm Med (2006) 0.92
Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest (2002) 0.91
Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients. Respir Res (2010) 0.91
Air travel for patients with chronic obstructive pulmonary disease: a case report. Br J Gen Pract (2012) 0.90
Asthma in the Elderly: Can We Distinguish It from COPD? J Allergy (Cairo) (2011) 0.90
Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis. Expert Opin Biol Ther (2006) 0.90
Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease. Respir Med (2004) 0.90
Expression analysis of angiogenic growth factors and biological axis CXCL12/CXCR4 axis in idiopathic pulmonary fibrosis. Connect Tissue Res (2010) 0.90
Biomarkers in COPD. Curr Med Chem (2007) 0.89
Decreased sputum mature dendritic cells in healthy smokers and patients with chronic obstructive pulmonary disease. Int Arch Allergy Immunol (2009) 0.89
Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean "real-life" experience. Pulm Pharmacol Ther (2011) 0.89
Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions. Respir Med (2008) 0.88
C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy. Eur J Clin Invest (2010) 0.88
Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in Idiopathic Pulmonary Fibrosis (IPF). Respir Med (2010) 0.88
Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study. Clin Dev Immunol (2010) 0.88
Effect of Mediterranean diet versus prudent diet combined with physical activity on OSAS: a randomised trial. Eur Respir J (2011) 0.88
Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients. Pulm Pharmacol Ther (2008) 0.87
Altered surfactant protein-A expression in type II pneumocytes in COPD. Chest (2009) 0.87
Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF). J Recept Signal Transduct Res (2010) 0.87
Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis. Respir Med (2007) 0.86
Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases. Chest (2011) 0.86
Bronchial artery embolization for management of massive cryptogenic hemoptysis: a case series. J Med Case Rep (2011) 0.86
Downregulation of lung mitochondrial prohibitin in COPD. Respir Med (2012) 0.86
Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity. Kidney Int (2005) 0.85
Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases. PLoS One (2011) 0.85
Pulmonary involvement and allergic disorders in inflammatory bowel disease. World J Gastroenterol (2010) 0.84
Sputum and nasal lavage lung-specific biomarkers before and after smoking cessation. BMC Pulm Med (2011) 0.84
Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions. Chest (2002) 0.84
Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis. BMC Pulm Med (2005) 0.84
Translation and validation of Berlin questionnaire in primary health care in Greece. BMC Pulm Med (2013) 0.83
Microsatellite DNA instability in benign lung diseases. Respir Med (2005) 0.83
Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome. Lung Cancer (2007) 0.83
Expression of FACIT collagens XII and XIV during bleomycin-induced pulmonary fibrosis in mice. Anat Rec A Discov Mol Cell Evol Biol (2003) 0.82
Continuous positive airway pressure therapy lowers vagal tone in patients with obstructive sleep apnoea-hypopnoea syndrome. Hellenic J Cardiol (2006) 0.82
8-Isoprostane, a marker of oxidative stress, is increased in the expired breath condensate of patients with pulmonary sarcoidosis. Chest (2004) 0.82
Immune and genetic mechanisms in COPD: possible targets for therapeutic interventions. Curr Drug Targets (2013) 0.82
Lymphangiogenesis in COPD: another link in the pathogenesis of the disease. Respir Med (2011) 0.82
Quality of life in patients with active sarcoidosis in Greece. Eur J Intern Med (2006) 0.82
Prediction of obstructive sleep apnea syndrome in a large Greek population. Sleep Breath (2010) 0.81
The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications. Exp Ther Med (2010) 0.81
Laser-assisted uvulopalatoplasty for the treatment of snoring and mild obstructive sleep apnea syndrome. J Otolaryngol (2003) 0.81
Effect of Mediterranean diet on lipid peroxidation marker TBARS in obese patients with OSAHS under CPAP treatment: a randomised trial. Sleep Breath (2011) 0.80
Histological expression of angiogenic factors: VEGF, PDGFRalpha, and HIF-1alpha in Hodgkin lymphoma. Pathol Res Pract (2008) 0.80
Role of VEGF-stromal cell-derived factor-1alpha/CXCL12 axis in pleural effusion of lung cancer. J Recept Signal Transduct Res (2010) 0.80
Somatic DNA alterations in lung epithelial barrier cells in COPD patients. Pulm Pharmacol Ther (2009) 0.79
Airway inflammation and cellular stress in noneosinophilic atopic asthma. Chest (2006) 0.79
Laboratory markers for COPD in "susceptible" smokers. Clin Chim Acta (2005) 0.79
Short telomeres and treatment of pulmonary fibrosis: implications for early intervention. Am J Respir Crit Care Med (2009) 0.79
Maintained smoking cessation for 6 months equilibrates the percentage of sputum CD8+ lymphocyte cells with that of nonsmokers. Mediators Inflamm (2010) 0.78
Granule cytotoxic activity and oxidative DNA damage in smoking and nonsmoking patients with asthma. Chest (2013) 0.78
A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy. Respiration (2006) 0.78
Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations. Respir Res (2006) 0.78
Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP). Sarcoidosis Vasc Diffuse Lung Dis (2004) 0.78
Investigation of angiogenetic pathways in nasal polyposis. Mol Med Rep (2012) 0.77
Perforin down-regulation and adhesion molecules activation in pulmonary sarcoidosis: an induced sputum and BAL study. Chest (2006) 0.77
Clearance of technetium-99m-DTPA and HRCT findings in the evaluation of patients with Idiopathic Pulmonary Fibrosis. BMC Pulm Med (2006) 0.77
Active remodeling in idiopathic interstitial pneumonias: evaluation of collagen types XII and XIV. J Histochem Cytochem (2006) 0.77
Erdheim-Chester disease: pulmonary presentation in a case with advanced systemic involvement. Respiration (2008) 0.77
Molecular response of the human diaphragm on different modes of mechanical ventilation. Respiration (2012) 0.77
Molecular profiling of EGFR family in chronic obstructive pulmonary disease: correlation with airway obstruction. Eur J Clin Invest (2013) 0.77
Investigation of IL-18 and IL-12 in induced sputum of patients with IPF before and after treatment with interferon gamma-1b. Sarcoidosis Vasc Diffuse Lung Dis (2005) 0.77
Cytokine network in the pathogenesis of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis (2005) 0.76